[Development of selective antitumor and antiprotozoal agents by linking to lysosomotropic carriers].
D000970:Antineoplastic Agents / Q000138:chemical synthesis*; D000981:Antiprotozoal Agents / Q000138:chemical synthesis*; D001665:Binding Sites; D004247:DNA; D008081:Liposomes; D008247:Lysosomes / Q000378:metabolism; D010455:Peptides; D014677:Pharmaceutical Vehicles
D000970:Antineoplastic Agents; D000981:Antiprotozoal Agents; D008081:Liposomes; D010455:Peptides; D014677:Pharmaceutical Vehicles; D004247:DNA
Développement de médicaments antitumoraux et antiprotozoaires sélectifs par association à des vecteurs lysosomotropes.